InvestSMART

Pacific Edge Limited (ASX:PEB)

ALERT: Price-sensitive ASX Announcement for PEB
Current share price for PEB : $0.210 -0.015 (-6.67%)+
Announcement
Release
3 Jun 2026 7:30AM
Price at Release
$0.225
Full Release
download
Summary
Pacific Edge Limited, a cancer diagnostics company, successfully raised NZ$36.1 million through a capital raising initiative, which included a NZ$25.4 million placement and a significantly oversubscribed NZ$10.7 million retail offer. The retail offer, originally set at NZ$6 million, accepted oversubscriptions due to strong demand, ultimately receiving applications for NZ$46 million worth of shares. The funds from this capital raise will support Pacific Edge’s strategic initiatives, reinforcing the company's strong position in the market and supporting the growth potential of its Cxbladder diagnostic tests, which are extensively utilized for bladder cancer detection and monitoring.
Key Points
  • Pacific Edge completes NZ$36.1 million capital raising.
  • Retail offer oversubscribed, raising NZ$10.7 million.
  • Strong support from existing shareholders, with over 93% participation.
  • Funds to support strategic initiatives and growth of Cxbladder tests.
  • New shares expected to begin trading on 4 June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.